CN102372680A - A kind of method for preparing thiazole-4-carboxylic acid - Google Patents

A kind of method for preparing thiazole-4-carboxylic acid Download PDF

Info

Publication number
CN102372680A
CN102372680A CN2011103602593A CN201110360259A CN102372680A CN 102372680 A CN102372680 A CN 102372680A CN 2011103602593 A CN2011103602593 A CN 2011103602593A CN 201110360259 A CN201110360259 A CN 201110360259A CN 102372680 A CN102372680 A CN 102372680A
Authority
CN
China
Prior art keywords
thiazole
thiazolidine
methyl
reaction
formic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2011103602593A
Other languages
Chinese (zh)
Inventor
邱滔
吴增辉
吕新宇
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Changzhou University
Original Assignee
Changzhou University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Changzhou University filed Critical Changzhou University
Priority to CN2011103602593A priority Critical patent/CN102372680A/en
Publication of CN102372680A publication Critical patent/CN102372680A/en
Pending legal-status Critical Current

Links

Images

Landscapes

  • Thiazole And Isothizaole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

本发明一种制备噻唑-4-甲酸的方法,属于精细化工中中间体合成的技术领域。制备步骤如下:以L-半胱氨酸盐酸盐与甲醛为起始原料,经缩合,酯化得到噻唑烷-4-甲酸甲酯,再在MnO2作用下氧化合成噻唑-4-甲酸甲酯,水解得到噻唑-4-甲酸。本发明的优点是采用价廉易得的L-半胱氨酸盐酸盐为原料,经缩合,酯化,氧化,水解值得产品,简化操作程序,降低生产成本。本发明具有反应条件温和、操作简单、转化率高、选择性好、工艺简单清洁的优点。

Figure 201110360259

The invention discloses a method for preparing thiazole-4-carboxylic acid, which belongs to the technical field of intermediate synthesis in fine chemical industry. The preparation steps are as follows: use L-cysteine hydrochloride and formaldehyde as starting materials, undergo condensation and esterification to obtain methyl thiazolidine-4-carboxylate, and then oxidize and synthesize methyl thiazole-4-carboxylate under the action of MnO2 Esters, hydrolyzed to give thiazole-4-carboxylic acid. The invention has the advantages of adopting cheap and easy-to-obtain L-cysteine hydrochloride as a raw material, condensing, esterifying, oxidizing, and hydrolyzing the worth product, simplifying the operation procedure and reducing the production cost. The invention has the advantages of mild reaction conditions, simple operation, high conversion rate, good selectivity and simple and clean process.

Figure 201110360259

Description

一种制备噻唑-4-甲酸的方法A kind of method for preparing thiazole-4-carboxylic acid

技术领域 technical field

    本发明一种制备噻唑-4-甲酸的方法,属于精细化工中间体合成的技术领域。 The invention relates to a method for preparing thiazole-4-carboxylic acid, which belongs to the technical field of synthesis of fine chemical intermediates.

背景技术 Background technique

噻唑-4-甲酸为合成噻苯咪唑的关键中间体,噻苯咪唑是最早研制的苯并咪唑类药物之一,1968年由美国默沙东公司开发成功,噻苯咪唑应用很广,主要作为抗寄生虫药物、杀菌剂和保鲜剂被广泛使用。 Thiazole-4-carboxylic acid is the key intermediate for the synthesis of thiabendazole. Thiabendazole is one of the earliest developed benzimidazole drugs. It was successfully developed by Merck in 1968. Thiabendazole is widely used, mainly as an anti-parasitic Insecticides, fungicides and preservatives are widely used.

李淑琏等报道的合成工艺,以丙酮酸为原料,经溴化制备溴代丙酮酸,然后和硫代甲酰胺环化制备噻唑-4-甲酸,也可由二氯丙酮与硫代甲酰胺反应制备噻唑-4-甲酸,再与邻苯二胺环合制备噻苯咪唑。该方法过程较复杂、污染较严重、反应收率较低。 The synthesis process reported by Li Shulian et al. uses pyruvic acid as a raw material, prepares bromopyruvic acid by bromination, and then cyclizes with thioformamide to prepare thiazole-4-carboxylic acid, and can also prepare thiazole by reacting dichloroacetone and thioformamide. -4-Formic acid, and then cyclized with o-phenylenediamine to prepare thiabendazole. The process of this method is more complicated, the pollution is more serious, and the reaction yield is lower.

Houssin, Raymond等报道的合成工艺,以溴代丙酮酸酯和硫脲环化缩合制备氨基噻唑-4-甲酸乙酯;氨基噻唑-4-甲酸乙酯经溴化制备溴代噻唑-4-甲酸乙酯,然后经过催化加氢脱溴生成噻唑-4-甲酸乙酯,对其进行水解制的噻唑-4-甲酸。该方法过程较复杂、污染较严重、反应收率较低。 The synthesis process reported by Houssin, Raymond, etc., prepares ethyl aminothiazole-4-carboxylate by cyclic condensation of bromopyruvate and thiourea; bromination of ethyl aminothiazole-4-carboxylate prepares bromothiazole-4-carboxylate Ethyl ester, and then undergo catalytic hydrodebromination to generate thiazole-4-carboxylic acid ethyl ester, which is hydrolyzed to produce thiazole-4-carboxylic acid. The process of this method is more complicated, the pollution is more serious, and the reaction yield is lower.

发明内容 Contents of the invention

本发明在现代有机合成的基础上,简化了实验步骤,降低了成本,原料价廉易得,溶剂易回收,在保证产品质量和收率的前提下,减少了污染物的生成量和能源的浪费。 On the basis of modern organic synthesis, the present invention simplifies the experimental steps, reduces the cost, the raw materials are cheap and easy to obtain, the solvent is easy to recycle, and on the premise of ensuring product quality and yield, the generation of pollutants and energy consumption are reduced waste.

本发明的一种制备噻唑-4-甲酸的方法,按照下述步骤进行: A kind of method for preparing thiazole-4-carboxylic acid of the present invention, carries out according to the following steps:

(1)缩合反应:以L-半胱氨酸盐酸盐为原料,采用一锅煮工艺,向其中加水,搅拌均匀后,加入质量浓度为37~40%的甲醛溶液,室温搅拌反应8 h,再向其中加入吡啶调节pH至中性,过滤,干燥,得到粗品;再用水-乙醇溶液重结晶,得到噻唑烷-4-甲酸。 (1) Condensation reaction: use L-cysteine hydrochloride as raw material, adopt a one-pot cooking process, add water to it, stir evenly, add formaldehyde solution with a mass concentration of 37~40%, stir at room temperature for 8 hours, and then Pyridine was added thereto to adjust the pH to neutral, filtered and dried to obtain the crude product; recrystallized from water-ethanol solution to obtain thiazolidine-4-carboxylic acid.

(2)酯化反应:以噻唑烷-4-甲酸为原料,向其中加入甲醇,搅拌均匀后开始通入干燥的氯化氢气体,至饱和,室温搅拌反应12 h,向其中加入乙醚,有白色片状晶体析出,抽滤干燥得噻唑烷-4-甲酸甲酯盐酸盐,脱盐酸盐后得到噻唑烷-4-甲酸甲酯; (2) Esterification reaction: use thiazolidine-4-carboxylic acid as raw material, add methanol to it, stir evenly, start to pass dry hydrogen chloride gas until saturated, stir at room temperature for 12 hours, add ether to it, there are white flakes crystals were precipitated, filtered and dried to obtain methyl thiazolidine-4-carboxylate hydrochloride, and methyl thiazolidine-4-carboxylate was obtained after dehydrochlorination;

(3)氧化反应:以噻唑烷-4-甲酸甲酯为原料,向其中加乙腈,搅拌均匀后,缓慢加入MnO2,60~100℃搅拌反应24-72h,冷却后过滤,滤液减压蒸馏除去溶剂,得到噻唑-4-甲酸甲酯; (3) Oxidation reaction: use methyl thiazolidine-4-carboxylate as raw material, add acetonitrile to it, stir evenly, then slowly add MnO 2 , stir and react at 60~100°C for 24-72h, filter after cooling, and distill the filtrate under reduced pressure Removal of solvent affords methyl thiazole-4-carboxylate;

(4)水解反应:以噻唑-4-甲酸甲酯为原料,向其中加入质量浓度10%的氢氧化钠水溶液,加热至回流1h,冷却,置冰浴中加入HCl溶液,酸化至pH=3,待析出固体,抽滤用少量水洗涤,烘干后得到噻唑-4-甲酸。 (4) Hydrolysis reaction: using methyl thiazole-4-carboxylate as raw material, add 10% sodium hydroxide aqueous solution to it, heat to reflux for 1 hour, cool, add HCl solution in ice bath, acidify to pH=3 , to be precipitated solid, suction filtration, washed with a small amount of water, and dried to obtain thiazole-4-carboxylic acid.

其中步骤(1)中所述缩合反应中n(L-半胱氨酸盐酸盐):n(甲醛)=1:1.05~1:1.4(摩尔比),反应过程中用水作溶剂,n(L-半胱氨酸盐酸盐):n(水)=1:5~1:8(摩尔比),水-乙醇溶液的体积比为1:1~1:1.5。 In the condensation reaction described in step (1), n (L-cysteine hydrochloride): n (formaldehyde) = 1:1.05~1:1.4 (molar ratio), water is used as a solvent during the reaction, n ( L-cysteine hydrochloride): n (water) = 1:5~1:8 (molar ratio), the volume ratio of water-ethanol solution is 1:1~1:1.5.

其中步骤(2)中所述酯化反应中n(噻唑烷-4-甲酸):n(甲醇)=1:35~1:45(摩尔比);n(噻唑烷-4-甲酸):n(乙醚)=1:47.5~1:97.5(摩尔比);氯化氢气体通入至饱和状态。 In the esterification reaction described in step (2), n (thiazolidine-4-carboxylic acid): n (methanol) = 1:35~1:45 (molar ratio); n (thiazolidine-4-carboxylic acid): n (Ethyl ether)=1:47.5~1:97.5 (molar ratio); hydrogen chloride gas is passed to saturation.

其中步骤(3)中所述氧化反应中n(噻唑烷-4-甲酸甲酯):n(MnO2)=1:20~1:26(摩尔比),n(噻唑烷-4-甲酸甲酯):n(乙腈)=1:200~1:230(摩尔比),反应时间为24~72h,反应温度为60~80℃。 In the oxidation reaction described in step (3), n(thiazolidine-4-methyl carboxylate):n(MnO 2 )=1:20~1:26 (molar ratio), n(thiazolidine-4-formyl carboxylate ester): n (acetonitrile)=1:200~1:230 (molar ratio), the reaction time is 24~72h, and the reaction temperature is 60~80℃.

其中步骤(4)中所述水解反应中n(噻唑-4-甲酸甲酯):n(氢氧化钠)=1:2.0~1:2.9(摩尔比)。 Wherein in the hydrolysis reaction described in step (4), n (methyl thiazole-4-carboxylate):n (sodium hydroxide)=1:2.0~1:2.9 (molar ratio).

  the

本发明的优点主要体现在以下方面:The advantages of the present invention are mainly reflected in the following aspects:

1. 该工艺采用廉价易得的L-半胱氨酸盐酸盐为原料,经缩合,酯化,氧化,水解制的产品,简化了操作程序,降低了操作成本。 1. This process uses cheap and easy-to-obtain L-cysteine hydrochloride as raw material, and the product is produced through condensation, esterification, oxidation and hydrolysis, which simplifies the operation procedure and reduces the operation cost.

2. 该工艺采用MnO2为氧化剂,乙腈作溶剂,反应条件温和。本发明与现有的合成路线相比具有反应条件温和、操作简单、转化率高、选择性好、工艺简单清洁的优点。 2. The process uses MnO2 as the oxidant, acetonitrile as the solvent, and the reaction conditions are mild. Compared with the existing synthetic routes, the present invention has the advantages of mild reaction conditions, simple operation, high conversion rate, good selectivity and simple and clean process.

附图说明:Description of drawings:

图1 本发明产品噻唑-4-甲酸的1H NMR 图谱, Fig. 1 The 1H NMR collection of books of product thiazole-4-carboxylic acid of the present invention,

图2 本发明产品噻唑-4-甲酸的质谱图谱。 Fig. 2 is the mass spectrogram of product thiazole-4-carboxylic acid of the present invention.

具体实施方式:Detailed ways:

下面的实例将对本发明予以进一步说明,但并不因此而限制本发明。 The following examples will further illustrate the present invention, but do not thereby limit the present invention.

实施例1 Example 1

步骤一: step one:

在150 mL单口烧瓶中加入25.0 g ( 0.14 mol ) L-半胱氨酸盐酸盐,20 mL 水,室温搅拌5 min,溶液呈白色透明,再向其中加入16.1 mL ( 0.192mol )37~40 % 甲醛溶液,继续反应8 h停止反应。向溶液中加入13 mL  ( 0.16 mol )99 % 吡啶溶液,搅拌,有白色固体析出。冷却后过滤,滤饼用体积比为水/乙醇 = 1∶1溶液重结晶,干燥,得白色针状晶体噻唑烷-4-甲酸16.1g,收率85%。m.p.191~192℃(文献值191℃~192℃)。 Add 25.0 g ( 0.14 mol ) L-cysteine hydrochloride and 20 mL water into a 150 mL single-necked flask, stir at room temperature for 5 min, the solution becomes white and transparent, then add 16.1 mL ( 0.192 mol ) 37-40 % formaldehyde solution, continue to react for 8 h to stop the reaction. Add 13 mL ( 0.16 mol ) 99 % pyridine solution to the solution, stir, and a white solid precipitates out. After cooling and filtering, the filter cake was recrystallized from a solution with a volume ratio of water/ethanol = 1:1, and dried to obtain 16.1 g of thiazolidine-4-carboxylic acid in the form of white needles, with a yield of 85%. m.p.191~192℃ (literature value 191℃~192℃).

步骤二: Step two:

在干燥的圆底烧瓶中,加入10.00 g(0.075mol)噻唑烷-4-甲酸,120 mL(2.96mol)甲醇,持续通入干燥HCl气体,至饱和。室温反应12h停止反应,加入200 mL(1.92mol)乙醚,有白色片状晶体析出,抽滤干燥得噻唑烷-4-甲酸甲酯盐酸盐,脱盐酸盐后得噻唑烷-4-甲酸甲酯9.84g,收率89%。 In a dry round bottom flask, add 10.00 g (0.075 mol) thiazolidine-4-carboxylic acid and 120 mL (2.96 mol) methanol, and continuously feed dry HCl gas until saturation. React at room temperature for 12 hours to stop the reaction, add 200 mL (1.92mol) of ether, white flaky crystals precipitate, filter and dry to obtain thiazolidine-4-carboxylic acid methyl ester hydrochloride, after dehydrochlorination to obtain thiazolidine-4-carboxylic acid methyl ester Esters 9.84g, yield 89%.

步骤三: Step three:

在250mL四口烧瓶中加入3.0 g(0.02mol)噻唑烷-4-甲酸甲酯,175mL乙腈,40g(0.46mol)MnO2。80℃搅拌反应48h。冷却后过滤,滤液减压蒸馏除去溶剂,得到噻唑-4-甲酸甲酯2.36 g,收率80.8%。 Add 3.0 g (0.02 mol) of methyl thiazolidine-4-carboxylate, 175 mL of acetonitrile, and 40 g (0.46 mol) of MnO 2 into a 250 mL four-neck flask. The reaction was stirred at 80°C for 48h. After cooling and filtering, the filtrate was distilled off under reduced pressure to remove the solvent to obtain 2.36 g of methyl thiazole-4-carboxylate with a yield of 80.8%.

步骤四: Step four:

在100mL三口烧瓶中加入2.0g (0.014mol) 噻唑-4-甲酸甲酯和12mL(0.03mol)10%的氢氧化钠水溶液,加热回流1 h,冷却,置冰浴中加入6 mol/L的HCl溶液,酸化至pH=3,待析出固体,抽滤,用少量水洗涤。烘干,得到产品噻唑-4-甲酸1.72g,收率95.6%。m.p.196~197℃(文献值:195~199℃)。 Add 2.0g (0.014mol) methyl thiazole-4-carboxylate and 12mL (0.03mol) 10% aqueous sodium hydroxide solution into a 100mL three-necked flask, heat to reflux for 1 h, cool, and add 6 mol/L of HCl solution, acidified to pH = 3, until the solid precipitated, suction filtered, washed with a small amount of water. After drying, 1.72 g of the product thiazole-4-carboxylic acid was obtained, with a yield of 95.6%. m.p.196~197℃ (literature value: 195~199℃).

实施例2 Example 2

步骤一,步骤二,同实施例1 Step one, step two, with embodiment 1

步骤三: Step three:

在250 mL四口烧瓶中加入3.0 g(0.02mol)噻唑烷-4-甲酸甲酯,175mL乙腈,35g(0.40mol)。80℃搅拌反应48h。冷却后过滤,滤液减压蒸馏除去溶剂,得到噻唑-4-甲酸甲酯2.07 g,收率70.8%。 Add 3.0 g (0.02mol) methyl thiazolidine-4-carboxylate, 175mL acetonitrile, 35g (0.40mol) into a 250 mL four-neck flask. The reaction was stirred at 80°C for 48h. After cooling and filtering, the filtrate was distilled off under reduced pressure to remove the solvent to obtain 2.07 g of methyl thiazole-4-carboxylate, with a yield of 70.8%.

步骤四同实施例1 Step 4 is the same as embodiment 1

实施例3 Example 3

步骤一,步骤二,同实施例1 Step one, step two, with embodiment 1

步骤三: Step three:

在250 mL四口烧瓶中加入3.0 g(0.02mol)噻唑烷-4-甲酸甲酯,175mL乙腈,30g(0.35mol)MnO2。80℃搅拌反应48h。冷却后过滤,滤液减压蒸馏除去溶剂,得到噻唑-4-甲酸甲酯1.88g,收率64.3%。 Add 3.0 g (0.02 mol) of methyl thiazolidine-4-carboxylate, 175 mL of acetonitrile, and 30 g (0.35 mol) of MnO 2 into a 250 mL four-neck flask. The reaction was stirred at 80°C for 48h. After cooling, it was filtered, and the solvent was distilled off from the filtrate under reduced pressure to obtain 1.88 g of methyl thiazole-4-carboxylate, with a yield of 64.3%.

步骤四同实施例1 Step 4 is the same as embodiment 1

实施例4 Example 4

步骤一,步骤二,同实施例1 Step one, step two, with embodiment 1

步骤三: Step three:

在250mL四口烧瓶中加入3.0 g(0.02mol)噻唑烷-4-甲酸甲酯,175mL乙腈,40g(0.46mol)MnO2。80℃搅拌反应24h。冷却后过滤,滤液减压蒸馏除去溶剂,得到噻唑-4-甲酸甲酯1.14g,收率39%。 Add 3.0 g (0.02 mol) of methyl thiazolidine-4-carboxylate, 175 mL of acetonitrile, and 40 g (0.46 mol) of MnO 2 into a 250 mL four-neck flask. The reaction was stirred at 80°C for 24h. After cooling, it was filtered, and the solvent was distilled off from the filtrate under reduced pressure to obtain 1.14 g of methyl thiazole-4-carboxylate, with a yield of 39%.

步骤四同实施例1 Step 4 is the same as embodiment 1

实施例5 Example 5

步骤一,步骤二,同实施例1 Step one, step two, with embodiment 1

在250mL四口烧瓶中加入3.0 g(0.02mol)噻唑烷-4-甲酸甲酯,175mL乙腈,40g(0.46mol)MnO2。80℃搅拌反应72h。冷却后过滤,滤液减压蒸馏除去溶剂,得到噻唑-4-甲酸甲酯2.38 g,收率81.4%。 Add 3.0 g (0.02 mol) of methyl thiazolidine-4-carboxylate, 175 mL of acetonitrile, and 40 g (0.46 mol) of MnO 2 into a 250 mL four-neck flask. The reaction was stirred at 80°C for 72h. After cooling and filtering, the filtrate was distilled off under reduced pressure to remove the solvent to obtain 2.38 g of methyl thiazole-4-carboxylate, with a yield of 81.4%.

步骤四同实施例1 Step 4 is the same as embodiment 1

实施例6 Example 6

步骤一,步骤二,同实施例1 Step one, step two, with embodiment 1

步骤三: Step three:

在250mL四口烧瓶中加入3.0g(0.02mol)噻唑烷-4-甲酸甲酯,175mL乙腈,40g(0.46mol)MnO2。70℃搅拌反应48h。冷却后过滤,滤液减压蒸馏除去溶剂,得到噻唑-4-甲酸甲酯1.98g,收率67.8%。 Add 3.0 g (0.02 mol) of methyl thiazolidine-4-carboxylate, 175 mL of acetonitrile, and 40 g (0.46 mol) of MnO 2 into a 250 mL four-neck flask. The reaction was stirred at 70°C for 48h. After cooling, it was filtered, and the solvent was distilled off from the filtrate under reduced pressure to obtain 1.98 g of methyl thiazole-4-carboxylate, with a yield of 67.8%.

步骤四同实施例1 Step 4 is the same as embodiment 1

实施例7 Example 7

步骤一,步骤二,同实施例1 Step one, step two, with embodiment 1

步骤三: Step three:

在250 mL四口烧瓶中加入3.0 g(0.02mol)噻唑烷-4-甲酸甲酯,175mL乙腈,40g(0.46mol)MnO2。60℃搅拌反应48h。冷却后过滤,滤液减压蒸馏除去溶剂,得到噻唑-4-甲酸甲酯1.73 g,收率59.2%。 Add 3.0 g (0.02 mol) of methyl thiazolidine-4-carboxylate, 175 mL of acetonitrile, and 40 g (0.46 mol) of MnO 2 into a 250 mL four-neck flask. The reaction was stirred at 60°C for 48h. After cooling and filtering, the filtrate was distilled off under reduced pressure to remove the solvent to obtain 1.73 g of methyl thiazole-4-carboxylate with a yield of 59.2%.

步骤四同实施例1 Step 4 is the same as embodiment 1

实施例8 Example 8

步骤一,步骤二,同实施例1 Step one, step two, with embodiment 1

步骤三: Step three:

在250 mL四口烧瓶中加入3.0 g(0.02mol)噻唑烷-4-甲酸甲酯,165 mL乙腈,40 g(0.46mol)300℃活化500min后的MnO2。80℃搅拌反应60 h。冷却后过滤,滤液减压蒸馏除去溶剂,得到噻唑-4-甲酸甲酯2.15 g,收率73.6%。 Add 3.0 g (0.02 mol) of methyl thiazolidine-4-carboxylate, 165 mL of acetonitrile, and 40 g (0.46 mol) of MnO 2 activated at 300°C for 500 min into a 250 mL four-neck flask. The reaction was stirred at 80°C for 60 h. After cooling and filtering, the filtrate was distilled off under reduced pressure to remove the solvent to obtain 2.15 g of methyl thiazole-4-carboxylate with a yield of 73.6%.

步骤四同实施例1 Step 4 is the same as embodiment 1

实施例9 Example 9

步骤一,步骤二,同实施例1 Step one, step two, with embodiment 1

步骤三: Step three:

在250 mL四口烧瓶中加入3.0 g(0.02mol)噻唑烷-4-甲酸甲酯,185 mL乙腈,40 g(0.46mol)300℃活化500min后的MnO2。80℃搅拌反应72h。冷却后过滤,滤液减压蒸馏除去溶剂,得到噻唑-4-甲酸甲酯2.35 g,收率80.4%。 Add 3.0 g (0.02 mol) of methyl thiazolidine-4-carboxylate, 185 mL of acetonitrile, and 40 g (0.46 mol) of MnO 2 activated at 300°C for 500 min into a 250 mL four-neck flask. The reaction was stirred at 80°C for 72h. After cooling and filtering, the filtrate was distilled off under reduced pressure to remove the solvent to obtain 2.35 g of methyl thiazole-4-carboxylate with a yield of 80.4%.

步骤四同实施例1 Step 4 is the same as embodiment 1

实施例10 Example 10

步骤一: step one:

在150 mL单口烧瓶中加入25.0 g ( 0.14 mol ) L-半胱氨酸盐酸盐,15 mL 水,室温搅拌5 min,溶液呈白色透明,再向其中加入16.1 mL ( 0.192mol )37~40 % 甲醛溶液,继续反应8 h停止反应。向溶液中加入13 mL  ( 0.16 mol )99 % 吡啶溶液,搅拌,有白色固体析出。冷却后过滤,滤饼用体积比为水/乙醇 = 1∶1溶液重结晶,干燥,得白色针状晶体噻唑烷-4-甲酸14.7g,收率78%。m.p.191~192℃(文献值191℃~192℃)。 Add 25.0 g ( 0.14 mol ) L-cysteine hydrochloride and 15 mL water into a 150 mL single-necked flask, stir at room temperature for 5 min, the solution turns white and transparent, then add 16.1 mL ( 0.192 mol ) 37-40 % formaldehyde solution, continue to react for 8 h to stop the reaction. Add 13 mL ( 0.16 mol ) 99 % pyridine solution to the solution, stir, and a white solid precipitates out. After cooling and filtering, the filter cake was recrystallized with a solution of water/ethanol = 1:1 by volume, and dried to obtain 14.7 g of white needle-like crystals of thiazolidine-4-carboxylic acid, with a yield of 78%. m.p.191~192℃ (literature value 191℃~192℃).

步骤二,步骤三,步骤四同实施例1 Step 2, step 3, step 4 are the same as embodiment 1

实施例11 Example 11

步骤一: step one:

在150 mL单口烧瓶中加入25.0 g ( 0.14 mol ) L-半胱氨酸盐酸盐,20 mL 水,室温搅拌5 min,溶液呈白色透明,再向其中加入14 mL ( 0.168mol )37~40 % 甲醛溶液,继续反应8 h停止反应。向溶液中加入13 mL  ( 0.16 mol )99 % 吡啶溶液,搅拌,有白色固体析出。冷却后过滤,滤饼用体积比为水/乙醇 = 1∶1溶液重结晶,干燥,得白色针状晶体噻唑烷-4-甲酸12.2g,收率64.7%。m.p.191~192℃(文献值191℃~192℃)。 Add 25.0 g ( 0.14 mol ) L-cysteine hydrochloride and 20 mL water into a 150 mL single-necked flask, stir at room temperature for 5 min, the solution becomes white and transparent, then add 14 mL ( 0.168 mol ) 37-40 % formaldehyde solution, continue to react for 8 h to stop the reaction. Add 13 mL ( 0.16 mol ) 99 % pyridine solution to the solution, stir, and a white solid precipitates out. After cooling and filtering, the filter cake was recrystallized with a solution of water/ethanol = 1:1 by volume, and dried to obtain 12.2 g of white needle-like crystals of thiazolidine-4-carboxylic acid, with a yield of 64.7%. m.p.191~192℃ (literature value 191℃~192℃).

步骤二,步骤三,步骤四同实施例1 Step 2, step 3, step 4 are the same as embodiment 1

实施例12 Example 12

步骤一: step one:

在150 mL单口烧瓶中加入25.0 g ( 0.14 mol ) L-半胱氨酸盐酸盐,20 mL 水,室温搅拌5 min,溶液呈白色透明,再向其中加入16.1 mL ( 0.192mol )37~40 % 甲醛溶液,继续反应8 h停止反应。向溶液中加入13 mL  ( 0.16 mol )99 % 吡啶溶液,搅拌,有白色固体析出。冷却后过滤,滤饼用体积比为水/乙醇 = 1∶1.2溶液重结晶,干燥,得白色针状晶体噻唑烷-4-甲酸11.5g,收率60.7%。m.p.191~192℃(文献值191℃~192℃)。 Add 25.0 g ( 0.14 mol ) L-cysteine hydrochloride and 20 mL water into a 150 mL single-necked flask, stir at room temperature for 5 min, the solution becomes white and transparent, then add 16.1 mL ( 0.192 mol ) 37-40 % formaldehyde solution, continue to react for 8 h to stop the reaction. Add 13 mL ( 0.16 mol ) 99 % pyridine solution to the solution, stir, and a white solid precipitates out. After cooling and filtering, the filter cake was recrystallized from a solution with a volume ratio of water/ethanol = 1:1.2, and dried to obtain 11.5 g of white needle-like crystals of thiazolidine-4-carboxylic acid, with a yield of 60.7%. m.p.191~192℃ (literature value 191℃~192℃).

步骤二,步骤三,步骤四同实施例1 Step 2, step 3, step 4 are the same as embodiment 1

实施例13 Example 13

步骤一同实施例1 Steps are the same as Example 1

步骤二: Step two:

在干燥的圆底烧瓶中,加入10.00 g(0.075mol)噻唑烷-4-甲酸,120 mL甲醇,持续通入干燥HCl气体,至饱和。室温反应12h停止反应,加入100 mL(0.96mol)乙醚,有白色片状晶体析出,抽滤干燥得噻唑烷-4-甲酸甲酯盐酸盐,脱盐酸盐后得噻唑烷-4-甲酸甲酯4.92g,收率44.5%。 In a dry round-bottomed flask, add 10.00 g (0.075 mol) thiazolidine-4-carboxylic acid and 120 mL methanol, and continuously feed dry HCl gas until saturation. React at room temperature for 12 hours to stop the reaction, add 100 mL (0.96mol) of ether, white flaky crystals precipitate, filter and dry to obtain thiazolidine-4-carboxylic acid methyl ester hydrochloride, after dehydrochlorination to obtain thiazolidine-4-carboxylic acid methyl ester Esters 4.92g, yield 44.5%.

步骤三步骤四同实施例1 Step 3 and step 4 are the same as in Example 1

实施例14 Example 14

步骤一同实施例1 Steps are the same as Example 1

步骤二: Step two:

在干燥的圆底烧瓶中,加入10.00 g(0.075mol)噻唑烷-4-甲酸,136.5mL(3.37mol)甲醇,持续通入干燥HCl气体。室温反应12h停止反应,加入200 mL(1.92mol)乙醚,有白色片状晶体析出,抽滤干燥得噻唑烷-4-甲酸甲酯盐酸盐,脱盐酸盐后得噻唑烷-4-甲酸甲酯9.85g,收率89%。 In a dry round bottom flask, add 10.00 g (0.075 mol) thiazolidine-4-carboxylic acid, 136.5 mL (3.37 mol) methanol, and continuously feed dry HCl gas. React at room temperature for 12 hours to stop the reaction, add 200 mL (1.92mol) of ether, white flaky crystals precipitate, filter and dry to obtain thiazolidine-4-carboxylic acid methyl ester hydrochloride, after dehydrochlorination to obtain thiazolidine-4-carboxylic acid methyl ester Esters 9.85g, yield 89%.

步骤三,步骤四同实施例1 Step three, step four are the same as embodiment 1

实施例15 Example 15

步骤一,步骤二,步骤三同实施例1 Step one, step two, step three are the same as embodiment 1

步骤四: Step four:

在100mL三口烧瓶中加入2.0g (0.014mol) 噻唑-4-甲酸甲酯和16mL(0.04mol)10%的氢氧化钠水溶液,加热回流1 h,冷却,置冰浴中加入6 mol/L的HCl溶液,酸化至pH=3,待析出固体,抽滤,用少量水洗涤。烘干,得到产品噻唑-4-甲酸1.61g,收率89.4%。m.p.196~197℃(文献值:195~199℃)。 Add 2.0g (0.014mol) methyl thiazole-4-carboxylate and 16mL (0.04mol) 10% sodium hydroxide aqueous solution into a 100mL three-necked flask, heat and reflux for 1 h, cool, and add 6 mol/L of HCl solution, acidified to pH = 3, until the solid precipitated, suction filtered, washed with a small amount of water. After drying, 1.61 g of the product thiazole-4-carboxylic acid was obtained, with a yield of 89.4%. m.p.196~197℃ (literature value: 195~199℃).

  the

噻唑-4-甲酸的结构表征:(见说明书附图1和2)Structural characterization of thiazole-4-carboxylic acid: (see Figures 1 and 2 of the specification)

MS m/z:129[M]+,112[M-OH]+,85[M-COOH]+ MS m/z:129[M] + ,112[M-OH] + ,85[M-COOH] +

1H NMR(C3H6O):δ:8.468(s,1H,N=C-H),9.086(s,1H,C=C-H) 。 1 H NMR (C 3 H 6 O): δ: 8.468 (s, 1H, N=CH), 9.086 (s, 1H, C=CH).

Claims (5)

1. method for preparing thiazole-4-formic acid is characterized in that carrying out according to following step:
(1) condensation reaction: with the L-cysteine hydrochloride is raw material, adopts the technology of treating different things alike, after wherein adding water, stirring; The adding mass concentration is 37 ~ 40% formaldehyde solution, and stirring at room is reacted 8 h, regulates pH to neutral to wherein adding pyridine again; Filter, drying obtains bullion; Water-ethanolic soln recrystallization obtains thiazolidine-4-formic acid again;
(2) esterification: with thiazolidine-4-formic acid is raw material, after wherein adding methyl alcohol, stirring, begins to feed the exsiccant hydrogen chloride gas; To saturated; Stirring at room is reacted 12 h, and to wherein adding ether, the adularescent tabular crystal is separated out; Dry thiazolidine-4-methyl-formiate the hydrochloride that gets of suction filtration obtains thiazolidine-4-methyl-formiate behind the desalination hydrochlorate;
(3) oxidizing reaction: with thiazolidine-4-methyl-formiate is raw material, after wherein adding acetonitrile, stirring, slowly adds MnO 2, 60 ~ 100 ℃ of stirring reaction 24-72h, cooled and filtered, the filtrate decompression distillation removes desolvates, and obtains thiazole-4-methyl-formiate;
(4) hydrolysis reaction: with thiazole-4-methyl-formiate is raw material, to the aqueous sodium hydroxide solution that wherein adds mass concentration 10%, is heated to backflow 1h; Adding HCl solution in the ice bath is put in cooling, is acidified to pH=3; Solid to be separated out, suction filtration washs with less water, obtains thiazole-4-formic acid after the oven dry.
2. a kind of method for preparing thiazole-4-formic acid according to claim 1; It is characterized in that wherein described in the step (1) molar ratio computing L-cysteine hydrochloride in the condensation reaction: formaldehyde=1:1.05 ~ 1:1.4; Use water as solvent in the reaction process; N molar ratio computing L-cysteine hydrochloride: water=1:5 ~ 1:8, the volume ratio of water-ethanol solution is 1:1 ~ 1:1.5.
3. a kind of method for preparing thiazole-4-formic acid according to claim 1 is characterized in that wherein described in the step (2) molar ratio computing thiazolidine-4-formic acid in the esterification: n methyl alcohol=1:35 ~ 1:45; Molar ratio computing thiazolidine-4-formic acid: ether=1:47.5 ~ 1:97.5; Hydrogen chloride gas feeds to state of saturation.
4. a kind of method for preparing thiazole-4-formic acid according to claim 1 is characterized in that wherein described in the step (3) molar ratio computing thiazolidine-4-methyl-formiate: MnO in the oxidizing reaction 2=1:20 ~ 1:26, molar ratio computing thiazolidine-4-methyl-formiate: acetonitrile=1:200 ~ 1:230, the reaction times is 24 ~ 72h, temperature of reaction is 60 ~ 80 ℃.
5. a kind of method for preparing thiazole-4-formic acid according to claim 1 is characterized in that wherein described in the step (4) molar ratio computing thiazole-4-methyl-formiate: sodium hydroxide=1:2.0 ~ 1:2.9 in the hydrolysis reaction.
CN2011103602593A 2011-11-15 2011-11-15 A kind of method for preparing thiazole-4-carboxylic acid Pending CN102372680A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2011103602593A CN102372680A (en) 2011-11-15 2011-11-15 A kind of method for preparing thiazole-4-carboxylic acid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2011103602593A CN102372680A (en) 2011-11-15 2011-11-15 A kind of method for preparing thiazole-4-carboxylic acid

Publications (1)

Publication Number Publication Date
CN102372680A true CN102372680A (en) 2012-03-14

Family

ID=45791966

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2011103602593A Pending CN102372680A (en) 2011-11-15 2011-11-15 A kind of method for preparing thiazole-4-carboxylic acid

Country Status (1)

Country Link
CN (1) CN102372680A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108047159A (en) * 2017-11-24 2018-05-18 江苏慈星药业有限公司 A kind of production technology of L- thiazolidines -4- carboxvlate hvdrochlorides

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4374249A (en) * 1980-12-23 1983-02-15 American Cyanamid Company [4R]-3-(ω-Aroylpropionyl)-4-thiazolidinecarboxylic acids and esters

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4374249A (en) * 1980-12-23 1983-02-15 American Cyanamid Company [4R]-3-(ω-Aroylpropionyl)-4-thiazolidinecarboxylic acids and esters

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
MASAHARU IWAKAWA,ET AL: "A FACILE SYNTHETIC APPROACH TO THE FRAGMENT D OF ANTIBIOTIC NOSIHEPTIDE, 2-[1-AMINO-3-CARBOXY-3-HYDR3S)-PROPYL]-THIAZOLE-4-CARBOXYLIC ACID", 《CHEMISTRY LETTERS》 *
PAUL W. R. HARRIS, ET AL: "Synthesis of proline-modified analogues of the neuroprotective agent glycyl-L-prolyl-glutamic acid (GPE)", 《TETRAHEDRON》 *
RAYMOND HOUSSIN,ET AL: "Design, Synthesis, and Pharmacological Evaluation of New Farnesyl Protein Transferase Inhibitors", 《J. MED. CHEM.》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108047159A (en) * 2017-11-24 2018-05-18 江苏慈星药业有限公司 A kind of production technology of L- thiazolidines -4- carboxvlate hvdrochlorides

Similar Documents

Publication Publication Date Title
CN103058989B (en) A kind of preparation method of α-lipoic acid
CN107936023B (en) Synthetic method of linagliptin intermediate
CN102229581B (en) Preparation method for febuxostat intermediate
CN102452972B (en) Method for preparing oxiracetam compound
CN112661662A (en) Preparation method of sodium 8- (2-hydroxybenzamido) caprylate
CN101463011B (en) A kind of synthetic method of 3,4-dihydropyrimidin-2-one
CN102372680A (en) A kind of method for preparing thiazole-4-carboxylic acid
CN115233243A (en) A kind of preparation method of 2,4,5-trisubstituted oxazole derivatives under electrocatalysis
CN103951561B (en) A kind of method for preparing L-menthol glyoxylate monohydrate by heteropolyacid catalysis
CN103497157B (en) 2-imidazolidone synthesis method
CN100537552C (en) A kind of method for preparing repaglinide
CN111848535B (en) A process for synthesizing 1H-tetrazoleacetic acid
CN113264843A (en) Synthetic method of 3-aminobicyclo [1.1.1] pentane-1-carboxylic ester derivative
CN101367767B (en) Room temperature solvent-free synthesis of 3,4-dihydropyrimidine-2-ketone
CN100528825C (en) Method for preparing camphorquinone through catalysis of metalloporphyrin and oxidation in air
CN102464699A (en) A kind of preparation method of sodium carbenate
CN101445479A (en) Method for synthesizing 1, 4-dihydropyridine
CN101391988B (en) Method for preparing 2- (4-hydroxyphenyl) -4-methyl-1, 3-thiazole-5-carboxylic acid ethyl ester by one-pot method
CN101575303B (en) Preparation method of 3- anilino-2-(3,4,5-trimethoxy benzyl) acrylonitrile
CN103319366A (en) Lacosamide synthesis technology
CN102898327B (en) Synthesis method for dimethyl azodicarboxylate and intermediate thereof
CN103058950A (en) Preparation method of febuxostat
CN1061985C (en) Method for preparation of progestol by degradation of steroidal saponin
CN101525278B (en) New synthetic method of guaiacol glycerin ether
CN1228312C (en) Process for synthesizing beta-amino acid using ketone as raw material

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20120314